The four new methodological Patient-Focused Drug Development guidance documents the FDA is currently developing for the industry that incorporate patient experience data into drug development, summarized.
Nadeeka R. Dias, PhD
Advertisement
Articles by Nadeeka R. Dias, PhD
Advertisement
Latest Updated Articles
FDA Patient-Focused Drug Development Guidance Update: Incorporating Patient Experience Data in Clinical TrialsPublished: May 28th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
